Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor γ and retinoid X receptor α in human keratinocytes

Cancer Research

Volumn 60, Issue 8, 2000, Pages 2247-2252

  Boudjelal, Mohamed ^a   Wang, Zengquan ^a   Voorhees, John J ^a   Fisher, Gary J ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SKIN CANCER; ULTRAVIOLET RADIATION;

AMINO ACID MOTIFS; CELLS, CULTURED; CYCLOHEXIMIDE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; KERATINOCYTES; KINETICS; LEUPEPTINS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TRANSFECTION; UBIQUITINS; ULTRAVIOLET RAYS;

EID: 0034655252     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Peck, G. L., and DiGiovanna, J. J. Synthetic retinoids in dermatology. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.), The Retinoids: Biology, Chemistry, and Medicine, Ed. 2, pp. 631-658. New York: Raven Press, 1994.
2. Marks, R. An overview of skin cancers: incidence and causation. Cancer (Phila.), 75: 607-612, 1995.
3. Fisher, G., and Voorhees, J. Molecular mechanisms of retinoid actions in skin. FASEB J., 10: 1002-1013, 1996.
4. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
5. Fisher, G. J., Talwar, H. S., Xiao, J. H., Datta, S. C., Reddy, A. P., Gaub, M. P., Rochette-Egly, C., Chambon, P., and Voorhees, J. J. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J. Biol. Chem., 269: 20629-20635, 1994.
6. Wang, Z. Q., Boudjelal, M., Kang, S., Voorhees, J. J., and Fisher, G. J. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pretreatment. Nat. Med., 4: 418-422, 1999.
7. Ward, C. L., Omura, S., and Kopito, R. R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell, 83: 121-127, 1995.
8. Griffiths, C. E. M., Rosenthal, D. S., Reddy, A., Elder, J. T., Astrom, A., Leach, K., Wang, T. S., Finkel, L. J., Yuspa, S. H., and Voorhees, J. J. Short-term retinoic acid treatment increases in vivo, but decreases in vitro, epidermal transglutaminase-K enzyme activity and immunoreactivity. J Investig. Dermatol., 99: 283-288, 1992.
9. Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L., and Rock, K. L. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem., 272: 13437-13445, 1997.
10. Dick, L. R., Cruikshank, A. A., Grenier, L., Melandri, F. D., Nunes, S. L., and Stein, R. L. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin β-lactone. J. Biol. Chem., 271: 7273-7276, 1996.
11. Treier, M., Staszewski, L. M., and Bohmann, D. Ubiquitin-dependent c-jun degradation in vivo is mediated by the delta domain. Cell, 78: 787-798, 1994.
12. Fisher, G. J., Esmann, J., Griffiths, C. E. M., Talwar, H. S., Duell, E. A., Hammerberg, C., Elder, J. T., Finkel, L. J., Karabin, G. D., and Nickoloff, B. J. Cellular, immunologic and biochemical characterization of topical retinoic-acid treated human skin. J. Investig. Dermatol., 96: 699-707, 1991.
13. Fisher, G. J., Reddy, A. P., Datta, S. C., Kang, S., Yi, J. Y., Chambon, P., and Voorhees, J. J. All-trans retinoic acid induces cellular retinol-binding protein in human skin in vivo. J. Investig. Dermatol., 105: 80-86, 1995.
14. Barrett, A. J., Kembhavi, A. A., Brown, M. A., Kirschke, H., Knight, C. G., Tamai, M., and Hanada, K. L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E-64), and its analogues as inhibitors of cysteine proteinases including cathepsins B, H, and L. Biochem. J., 201: 189-198, 1982.
15. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 78: 761-771, 1994.
16. Coux, O., Tanaka, K., and Goldberg, A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem., 65: 801-847, 1996.
17. Gaczynska, M., Rock, K. L., and Goldberg, A. L. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature (Lond.), 365: 264-267, 1993.
18. Hochstrasser, M. Ubiquitin, and intracellular protein degradation. Curr. Opin. Cell Biol., 4: 1024-1031, 1992.
19. Rechsteiner, M., Hoffman, L., and Dubiel, W. The multicatalytic and 26S proteases. J. Biol. Chem., 268: 6065-6068, 1993.
20. Rogers, S., Wells, R., and Rechsteiner, M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (Washington DC), 234: 364-368, 1986.
21. Lin, R., Beauparlant, P., Makris, C., Meloche, S., and Hiscott, J. Phosphorylation of [κBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol., 16: 1401-1409, 1996.
22. Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., and O'Malley, B. W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA, 96: 1858-1862, 1999.
23. Rechsteiner, M., and Rogers, S. W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci., 21: 267-271, 1996.
24. Roth, A. F., Sullivan, D. M., and Davis, N. G. A large PEST-like sequence directs the ubiquitination, endocytosis, and vacuolar degradation of the yeast a-factor receptor. J. Cell Biol., 142: 949-961, 1998.
25. Masuyama, H., and MacDonald, P. N. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUGI interaction with the AF-2 domain of VDR. J. Cell. Biochem., 71: 429-440, 1998.
26. Li, X. Y., Boudjelal, M., Xiao, J. H., Peng, Z. H., Asuru, A., Kang, S., Fisher, G. J., and Voorhees, J.J. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol. Endocrinol., 13: 1686-1694, 1999.
27. Nirmala, P., and Thampan, R. Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem. Biophys. Res. Commun., 213: 24-31, 1995.
28. Alarid, E., Bakopoulos, N., and Solodin, N. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol., 9: 1522-1534, 1999.